A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
Top Cited Papers
- 15 March 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (6) , 961-965
- https://doi.org/10.1016/s0735-1097(02)03014-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Results of CURE Trial for Acute Coronary SyndromePublished by American Medical Association (AMA) ,2001
- Erythrocyte Promotion of Platelet Reactivity Decreases the Effectiveness of Aspirin as an Antithrombotic Therapeutic ModalityCirculation, 1998
- Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and ProphylaxisSeminars in Thrombosis and Hemostasis, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994
- Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patientsThrombosis Research, 1993
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patientsThrombosis Research, 1991
- Sex difference in antithrombotic effect of aspirin.Stroke, 1989